Company Overview and News

 
Not too skimpy: US apparel giant buys Bras N Things in $500m deal

2018-02-08 theage.com.au
American apparel giant Hanesbrands has snapped up Australian lingerie retailer Bras N Things in a not-so-skimpy deal worth half a billion dollars. 
Upvote Downvote

 
Not too skimpy: US apparel giant buys Bras N Things in $500m deal

2018-02-08 smh.com.au
American apparel giant Hanesbrands has snapped up Australian lingerie retailer Bras N Things in a not-so-skimpy deal worth half a billion dollars. 
Upvote Downvote

1
HanesBrands: Undervalued And Sell-Off Overdone

2017-11-21 seekingalpha
HanesBrands (NYSE: HBI) stock price has come under pressure, reaching 52-week lows in the past week, which has sparked my interest to evaluate the company. HanesBrands reported revenue and earnings in-line with analyst consensus estimates for the third quarter; however, the company provided slightly lower than expected guidance for the fourth quarter which was one of the perceived reasons for the sell-off.
Upvote Downvote

 
ATO defends fraud systems after Cranston scandal

2017-10-12 smh.com.au
The Australian Taxation Office's systems to detect and prevent fraud are working, says Second Commissioner Andrew Mills, but there's always room for improvement.
Upvote Downvote

 
ATO defends fraud systems after Cranston scandal

2017-10-12 theage.com.au
The Australian Taxation Office's systems to detect and prevent fraud are working, says Second Commissioner Andrew Mills, but there's always room for improvement.
Upvote Downvote

 
The High Points From Hanesbrands Inc.'s Q2 2017 Report

2017-08-08 fool
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.
Upvote Downvote

 
Hanesbrands (HBI) Q2 2017 Results - Earnings Call Transcript

2017-08-02 seekingalpha
Good day, ladies and gentlemen, and welcome to the Hanesbrands Second Quarter 2017 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we'll conduct a question-and-answer session and instructions will follow at that time. As a reminder, this conference is being recorded.
Upvote Downvote

 
Comparing Hanesbrand to a Warren Buffett Acquisition

2017-07-29 fool
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.
Upvote Downvote

 
Campbell Soup Company - Why Legacy Products Will Die A Slow Death

2017-07-19 seekingalpha
These types of moves are necessary from a long-term competitive perspective resulting from consumer preference changes.
Upvote Downvote

 
Perpetual cops a Brickworks through the window

2017-07-10 theage.com.au
The Federal Court has thrown a brick through the windows of investment house Perpetual. And not before too long if you're sitting in the Millner family's camp.Justice Jayne Jagot is the thrower-in-chief after she found the cross-holdings of Brickworks and Washington H. Soul Pattinson linked to the Millners did not impact on teeny tiny shareholders such as one of Australia's largest wealth managers.
Upvote Downvote

 
Perpetual cops a Brickworks through the window

2017-07-10 smh.com.au
The Federal Court has thrown a brick through the windows of investment house Perpetual. And not before too long if you're sitting in the Millner family's camp.Justice Jayne Jagot is the thrower-in-chief after she found the cross-holdings of Brickworks and Washington H. Soul Pattinson linked to the Millners did not impact on teeny tiny shareholders such as one of Australia's largest wealth managers.
Upvote Downvote

 
Wesfarmers left with $2.5m bill for Kiwi soldiers' leaking raincoats

2017-06-22 theage.com.au
Socks and jocks maker Pacific Brands sold a shipment of leaking rain jackets to the New Zealand Defence Force and then left Wesfarmers to cover the $2.5 million cost of replacing them. 
Upvote Downvote

 
Wesfarmers left with $2.5m bill for Kiwi soldiers' leaking raincoats

2017-06-22 smh.com.au
Socks and jocks maker Pacific Brands sold a shipment of leaking rain jackets to the New Zealand Defence Force and then left Wesfarmers to cover the $2.5 million cost of replacing them. 
Upvote Downvote

 
Wesfarmer left with $2.5m bill for Kiwi soldiers' leaking raincoats

2017-06-22 theage.com.au
Socks and jocks maker Pacific Brands sold a shipment of leaking rain jackets to the New Zealand Defence Force and then left Wesfarmers to cover the $2.5 million cost of replacing them. 
Upvote Downvote

 
Wesfarmer left with $2.5m bill for Kiwi soldiers' leaking raincoats

2017-06-22 smh.com.au
Socks and jocks maker Pacific Brands sold a shipment of leaking rain jackets to the New Zealand Defence Force and then left Wesfarmers to cover the $2.5 million cost of replacing them. 
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...